Stress at an early age changes the DNA in brain cells

The focus was on the ventral fascicle, the area of the brain where dopamine neurons are located. They participate in evaluating important environmental events, including rewards and threats. If these cells start working incorrectly, reward processing is disrupted, and the person becomes more vulnerable to anxiety and depression.

Inside the neurons, the researchers focused on the epigenome, the molecular markers that control the availability of genes. The analogy used by the authors of the study is very clear: DNA in a cell is wound around histone proteins like a spring. If such a spring is tightly compressed, the genes are inaccessible and turned off. If it is stretched, the DNA regions become open, and the genes are more easily activated.

The enzyme SETD7 plays a key role in this process. In young mice that had experienced stress, the level of SETD7 in dopamine neurons was higher than in animals from normal conditions. SETD. places a specific chemical mark (H3K4me1) on the DNA structure, which precisely marks the site for unwinding. As a result, the spring remains stretched, and the cell becomes hyperreactive; it is easier for it to activate the genes responsible for stress.

To test the cause‑and‑effect relationship, the scientists artificially increased the level of SETD7 in young mice that had not been exposed to stress. Even without a traumatic experience, these animals developed an elongated DNA structure in their dopamine cells in adulthood; they tolerated stress poorly, exhibited more anxious behavior, and had increased neuronal reactivity.

The reverse experiment yielded equally important results. If, after early stress, the activity of SETD7 is blocked so that it does not add too many H3K4me1 marks, the DNA remains in a more compressed state. Such mice, even after experiencing both early and adult stress, maintained normal social and exploratory behavior, similar to that of animals that had never experienced stress. Their dopamine neurons functioned normally.

This means that SETD7 and the associated epigenetic mark represent a specific molecular mechanism through which early stress is encoded in brain cells and determines vulnerability to mental disorders in the future.

Currently, there are no treatment methods that specifically address the changes in the brain caused by early stress, partly because there has been no clear understanding of which molecular pathways need to be targeted. The authors also emphasize the importance of non‑pharmacological approaches. If a child’s critical developmental periods are supported by care, therapy, and social resources, the impact of stress can be mitigated and the epigenome can be prevented from becoming fixed in an open state. This can help the brain develop natural resilience.

The study reveals a specific biological pathway through which early adverse experiences reshape the brain: via the enzyme SETD7 and an epigenetic mark, it alters the packaging of DNA in dopamine neurons, making the genes involved in the stress response constantly ready to be activated. Understanding this mechanism opens up prospects both for the development of new medications and for targeted support programs for children during vulnerable periods of development.